Systemic diffuse large B-cell lymphoma involving the central nervous system have high rates of defective antigen presentation and immune surveillance

Haematologica. 2024 Mar 21. doi: 10.3324/haematol.2023.284600. Online ahead of print.

¹ Austin Health, Heidelberg, Australia; Olivia Newton John Cancer Research Institute, Victoria, Australia; The University of Melbourne, Melbourne, Australia; Townsville University Hospital, Townsville. joel.wight@health.qld.gov.au.
² Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. 7. Princess Alexandra Hospital, Brisbane.
³ Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria.
⁴ Princess Alexandra Hospital, Brisbane.
⁵ Mater Research Institute, The University of Queensland, Brisbane.
⁶ Princess Alexandra Hospital, Brisbane, Australia; Mater Research Institute, The University of Queensland, Brisbane, Australia; University of Queensland, Brisbane.
⁷ Townsville University Hospital, Townsville.
⁸ Princess Alexandra Hospital, Brisbane, Australia; University of Queensland, Brisbane.
⁹ Austin Health, Heidelberg, Australia; Olivia Newton John Cancer Research Institute, Victoria, Australia; The University of Melbourne, Melbourne, Australia; La Trobe University, Melbourne.

Abstract

Not available.